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Langerhans Cell Resistance, CD11bþ Cell Inﬂux, and Cytokine
mRNA Expression in Skin after UV Exposure in Patients with
Polymorphous Light Eruption as Compared with Healthy
Control Subjects
To the Editor:
The etiology and exact pathogenesis of polymorphous light
eruption (PLE) are unknown (Mastalier et al, 1998). Ko¨lgen
et al (1999) recently reported that Langerhans cells (LC)
were more resistant to ultraviolet radiation (UVR) in patients
with PLE than in healthy control subjects and that the influx
of CD11bþ macrophages (Kang et al, 1998) into the dermis
upon experimental UVR exposure was increased more in
the PLE-afflicted patients. They hypothesized that in PLE
patients, these abnormal responses may increase the
immunoreactivity of the skin to one or more sunlight-
induced neoantigens, resulting in the skin rash character-
istic of the disease.
In the study described here, we asked whether the
disturbed immune function seen in PLE might be due to
some abnormal UVR-induced response to immunomodula-
tory cytokines (e.g., tumor necrosis factor (TNF)-a, inter-
leukin (IL)-1-b, IL-10, and IL-12). TNF-a and IL-1-b have
been linked to UVR-induced migration of LC (Cumberbatch
et al, 1997), and IL-10 has been linked to impaired antigen-
presenting function of LC (Enk et al, 1993). IL-12 disposes
the skin toward development of a Th1 response that is
crucial for the induction of contact hypersensitivity, and it
can abrogate the immunosuppressive effects of UVR
(Schwarz et al, 1996).
Twelve patients with PLE and 12 healthy, sex- and age-
matched volunteer (control) subjects were recruited for this
study. The demographic characteristics of the patients with
PLE were as follows: sex (three men, nine women), age
range (30–63 y), median age (48 y), and skin phototype (II
in four patients; III in eight patients). The demographic
characteristics of the control subjects were as follows: sex
(three men, nine women), age range (32–61 y), median age
(44 y), and skin phototype (II in six patients, III in six
patients).
This study was conducted during a period of the year
when environmental sunlight radiation was low (November
to April) so as to minimize the interference of sunlight with
the artificial ultraviolet (UV) exposure required for the study.
Solar-simulated (SS) UVR was generated by an Oriel 1000
Watt solar simulator (Oriel Corp., Darmstadt, Germany)
equipped with a dichroic mirror, an atmospheric attenuation
filter (WG320/1 mm), and a UG5/1 mm visible–infrared light
bandpass blocking filter. The mean minimum erythema
dose (MED) on the upper left buttock at 24 h after SS UVR
exposure in the PLE subjects and healthy control subjects
was 6.0 J per cm2 (range, 3.2–9.1 J per cm2) and 6.1 J
per cm2 (range, 3.2–12.9 J per cm2), respectively. After
randomization of each subject to the SS UVR MED
treatment, two 1.5-cm-diameter areas on the upper right
buttock of each subject were exposed to doses of SS UVR
equivalent to one, two, or three times the individual MED.
Three punch biopsies, each 4 mm in diameter, were taken
from the buttocks of each subject: one from an unirradiated
area of skin (as a control) at 0 h and two from SS UVR-
exposed areas of skin at 6 and 24 h after exposure,
respectively.
To isolate total RNA, 20-mm-thick sections were cut from
the frozen punch biopsies, collected in 50-mL sample
tubes, and subsequently powdered and pulverized under
liquid nitrogen. RNA extraction was performed using
RNeasy Mini Kit (Quiagen, Germany). Reverse transcription
was performed using TaqMan reverse transcription re-
agents (PE Applied Biosystems, Warrington, United King-
dom), followed by real-time PCR assays (TaqMan PCR) with
pre-developed primers for TNF-a, IL-1-b, IL-10, IL-12p35,
and 18S rRNA (TaqMan Assay Reagents; PE Biosystems).
Each PCR run included a control sample containing no
template and a calibrator sample (i.e., RNA from normal,
non-UV-irradiated skin), and analysis was performed using
the DDCt method (Brink et al, 2000).
For statistical analysis, the gene expression data were
first normalized and log transformed and then subjected
to repeated measures analysis. A multivariate normal error
distribution was assumed for the triplicate PCR assays
performed for each subject. The statistical model assumed
that gene expression in the PLE patients as compared
with the healthy control subjects would be the same in the
absence of UVR exposure but different after UVR exposure.
UVR dose (i.e., MED) was included as a covariant. The
statistical analysis, which was carried out using the
statistical software program SAS PROC GENMOD (SAS
Institute, Cary, North Carolina, USA), revealed that after SS
UVR exposure the expression of TNF-a mRNA was
significantly upregulated up to 3.9-fold (with a peak at 6 h)
Abbreviations: IL, interleukin; LC, Langerhans cells; MED, mini-
mum erythema dose; PLE, polymorphous light eruption; SS, solar
simulated; TNF, tumor necrosis factor; UV, ultraviolet; UVR,
ultraviolet radiation
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(p¼ 0.0002), that of IL-1-b mRNA up to 77-fold (with a peak
at 6 h) (po0.0001), and that of IL-10 mRNA up to 14-fold
(with a peak at 24 h) (p¼0.003). It also revealed that the
effect of SS UVR on TNF-a, IL-1-b, and IL-10 mRNA
expression was significantly dependent on the MED
(p¼ 0.02, po0.006, and p¼ 0.01, respectively). The levels
of these three cytokines before and after UV exposure,
however, did not significantly differ between PLE subjects
and healthy control subjects. The results for IL-12 were
inconsistent and varied widely.
To analyze the disposition of LC (CD1aþ cells) and
macrophages (CD11bþor CD68þ cells) in the skin after
SS UVR exposure, the remaining portions of frozen biopsy
specimens from a matched subset of PLE subjects (n¼6)
and healthy control subjects (n¼7) were sectioned and
then immunohistochemically stained (Table I). Immunostain-
ing was performed in an automated immunostainer (Hor-
izon; DAKO A/S, Glostrup, Denmark) using monoclonal
antibodies against CD1a (clone NA1/34,1:50), CD11b (clone
2LPM19c, 1:50), and CD68 (clone EBM11, 1:50) (all from
Table I. Disposition of LC and CD11bþ and CD68þ cells in the skin of PLE patients and healthy control subjects
after SS UVR exposure
Cells
Healthy control subjects PLE subjects
Subject
Epidermis Dermis Epidermis Dermis
0 h 24 h 0 h 24 h 0 h 24 h 0 h 24 h
CD1aþ 1 þ  /   þ  /  
2 þ þ    / þ   
3 þ þ   /  þ þ þ   /
4 þ  /   þ þ þ  
5 þ þ    / þ þ    /
6 þ þ    þ þ  /  
7 þ þ þ   /
Median þ þ þ /   þ þ þ /   /
p-Value 0.0180 0.0431 0.0273 NS
CD11bþ 1    þ þ /þ   /  þ
2   / þ /  þ þ   /  þ þ
3   þ þ þ    þ
4    þ þ /þ   þ þ þ
5    þ þ  þ /  þ þ þ
6    þ  þ  þ þ
7  þ þ þ þ þ
Median    þ þ   /  þ þ
p-Value 0.0431 0.0277 NS 0.0277
CD68þ 1    þ    
2   þ þ  /   þ / 
3  /  / þ þ  /  /  
4   / þ /  þ þ /þ  /  /  þ
5  /  / þ þ  /  þ /  þ
6  /  / þ þ    þ
7 þ /  þ /  þ þ þ þ
Median  /  / þ þ  /  /  þ / 
p-Value NS NS NS NS
Immunohistochemically stained skin sections were evaluated independently by two investigators (A.W. and B.B.), both of whom were blinded to SS
UVR exposure status, by light microscopy (  250 magnification) for the presence of stained (positive) cells, according to the following scoring system:
þ þ , closed maze; þ , clear abundance;  , scattered presence; , and little or no presence of positive cells. In cases where the scoring of the
investigators differed, both scores are given, and the average score is used for statistical analysis. The p-values shown are for comparisons between
scores at 24 h vs 0 h and were determined by using the Wilcoxon rank-sum test. po0.05 was considered statically significant. NS, not significant.
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DAKO A/S). Exposure to SS UVR resulted in a significant
reduction in the number of CD1aþ cells in the epidermis
and a significant influx of macrophages (CD11bþ cells) into
the dermis of both PLE patients and healthy control
subjects at 24 h (but not at 6 h). In contrast to a previous
study (Ko¨lgen et al, 1999), however, the levels of CD1aþ or
CD11bþ cells did not significantly differ between PLE
patients and healthy control subjects before UV exposure or
at 6 and 24 h after UV exposure. Moreover, SS UVR had no
statistically significant effect on the numbers of CD68þ
cells in the epidermis and dermis or on the numbers of such
cells in PLE patients as compared with healthy control
subjects.
There may be several reasons for the apparent differ-
ences between the results of our study and the study of
Ko¨lgen et al (1999). First, the fact that half of the PLE
patients in the other study (n¼5; two men, three women;
age range, 28–49 y) had a normal MED and the other
half (n¼5; all men; age range, 45–82 y) had a low MED
appeared to influence the results of UV exposure: the
differences in LC resistance and influx of CD11bþ cell
observed by Ko¨lgen et al were more pronounced between
the healthy control subjects (n¼8; four men, four women;
age range, 21–43 y) and those PLE patients with the low
MED than between the same healthy controls and those
PLE patients with the normal MED. In contrast, all of the
PLE subjects and healthy control subjects in our study had
a normal MED and a similar mean MED. Second, the sex
and age matching in our study was better and more typical
of PLE than that in the former study. The female/male ratio
in our study was 4:1 as compared with 3:7 in the other
study. All of the PLE patients with a low MED in the study of
Ko¨lgen et al were men who were not only older than the
other PLE patients and the healthy subjects but also
showed the most profound differences in cell counts when
compared with the healthy control subjects. Third, no SS
UVR was used by Ko¨lgen et al, since their light source, a
Philips TL12 lamp, does not emit such radiant light. Fourth,
Ko¨lgen et al, used a much higher (possibly more irrelevant)
UV dose than we did (six MED versus two MED). Fifth,
Ko¨lgen et al counted cells at 48 and 72 h after UV exposure,
whereas we counted them at 6 and 24 h.
In a more recent study, Ko¨lgen et al (2003) found that less
TNF-a, IL-4, and IL-10 protein was expressed in the UVB-
irradiated skin of PLE patients (one men, five women; age
range, 32–64 y) than in that of healthy volunteer subjects
(two men, three women; age range, 19–21 y). When we tried
to reproduce these findings on the mRNA level, however,
we found no difference between PLE patients and healthy
subjects. The discrepancy between our findings and those
of Ko¨lgen et al may be due to differences in the age
distribution and the MED of the patients studied. We believe
that the patient population we studied more accurately
reflects that seen in patients with PLE. Therefore, in light of
our present results, we conclude that neither an abnormal
resistance of LC nor an increased influx of macrophages in
response to UVR or an abnormal mRNA regulation of
immunomodulatory cytokines contributes to the pathogen-
esis of PLE.
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